載入...

Successful Alectinib Treatment for Carcinoma of Unknown Primary with EML4-ALK Fusion Gene: A Case Report

Gene alteration in anaplastic lymphoma kinase (ALK) is rare, and the efficacy of ALK inhibitors in the treatment of carcinoma of unknown primary (CUP) with ALK alteration remains unclear. The patient was a 56-year-old woman who presented with cervical lymph node swelling. Computed tomography reveale...

全面介紹

Na minha lista:
書目詳細資料
發表在:Curr Oncol
Main Authors: Sugiyama, Keiji, Izumika, Ai, Iwakoshi, Akari, Nishibori, Riko, Sato, Mariko, Shiraishi, Kazuhiro, Hattori, Hiroyoshi, Nishimura, Rieko, Kitagawa, Chiyoe
格式: Artigo
語言:Inglês
出版: MDPI 2021
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8161847/
https://ncbi.nlm.nih.gov/pubmed/34064158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/curroncol28030180
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!